Unlock instant, AI-driven research and patent intelligence for your innovation.

Non-human animals having a genome comprising an engineered diversity cluster within an immunoglobulin heavy chain variable region and use thereof

An immunoglobulin and variable region technology, applied in immunoglobulins, peptides, chemical instruments and methods, etc.

Active Publication Date: 2018-11-09
REGENERON PHARM INC
View PDF41 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the development of particularly potent antibody reagents that bind recalcitrant targets remains a challenge

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Non-human animals having a genome comprising an engineered diversity cluster within an immunoglobulin heavy chain variable region and use thereof
  • Non-human animals having a genome comprising an engineered diversity cluster within an immunoglobulin heavy chain variable region and use thereof
  • Non-human animals having a genome comprising an engineered diversity cluster within an immunoglobulin heavy chain variable region and use thereof

Examples

Experimental program
Comparison scheme
Effect test

example

[0364] The following examples are provided to describe to those of ordinary skill in the art how to make and use the methods and compositions disclosed herein, and are not intended to limit the scope of what the inventors regard as their invention. Unless indicated otherwise, temperature is given in degrees Celsius and pressure is at or near atmospheric.

example 1

[0365] Example 1. Construction of engineered diversity clusters comprising nucleotide coding sequences for D6 chemokine decoy receptors within immunoglobulin heavy chain variable regions

[0366] This example illustrates an exemplary method for constructing a targeting vector for insertion into the genome of a non-human animal, such as a rodent (eg, mouse). In particular, the methods described in this example demonstrate the generation of targeting vectors for insertion into the genome of rodent (e.g., mouse) embryonic stem (ES) cells to produce immunoglobulin heavy chain variable The rodent of the immunoglobulin heavy chain variable region comprising engineered heavy chain diversity (D H ) area, the modified D H A region includes one or more nucleotide sequences each encoding a non-immunoglobulin polypeptide or a portion thereof. In this example, the coding sequence of the extracellular domain of an atypical chemokine receptor (ACKR), such as the D6 chemokine decoy receptor...

example 2

[0377] Example 2. Generation of Rodents with an Engineered Diversity Cluster Including the Nucleotide Encoding Sequence of a D6 Chemokine Decoy Receptor Within an Immunoglobulin Heavy Chain Variable Region

[0378] This example demonstrates the generation of a non-human animal (e.g., a rodent) whose genome comprises an immunoglobulin heavy chain variable region comprising an engineered heavy chain diversity (D H ) region, wherein the modified D H A region comprises one or more nucleotide sequences each encoding a portion of a non-immunoglobulin polypeptide, particularly an atypical chemokine receptor (ACKR), eg, the extracellular portion of the D6 chemokine decoy receptor.

[0379] The D6-D described in Example 1 was confirmed by sequencing using the primers set forth in Table 6 and by polymerase chain reaction throughout the construction of the targeting vector H Proper assembly of the targeting vector and targeted insertion of the D6 DNA fragment within the diversity cluste...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Non-human animals and methods and compositions for making and using them are provided, wherein said non-human animals have a genome comprising an engineered or recombinant diversity cluster within animmunoglobulin heavy chain variable region, which engineered or recombinant diversity cluster comprises an insertion of one or more coding sequences of a non-immunoglobulin polypeptide of interest. Non-human animals described herein express antibodies characterized by complementary determining regions (CDRs), in particular, CDR3s having diversity that directs binding to particular antigens. Methods for producing antibodies from non-human animals are also provided, which antibodies contain human variable regions and mouse constant regions.

Description

Background technique [0001] Antibody-based therapeutics offer significant promise for the treatment of a variety of diseases. Various formats are being developed, including monoclonal, murine, chimeric, humanized, human, full-length, Fab, pegylated, radiolabeled, drug-conjugated, multispecific, etc. (see e.g. Reichert, J.M., 2012, mAbs 4:3, 413-415; Nixon, A.E. et al., 2014, mAbs 6:1, 73-85; incorporated herein by reference). Of the more than 40 therapeutic antibody reagents that have been licensed for marketing in the United States or Europe, all rely on human and / or non-human ( For example, conventional antibody gene assembly techniques of mouse) origin are produced. However, the development of particularly potent antibody reagents that bind recalcitrant targets remains a challenge. Contents of the invention [0002] Disclosed herein is the recognition that it is desirable to engineer non-human animals to allow improved in vivo systems for the identification and develop...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A01K67/027C07K16/00
CPCA01K67/0275C07K16/00C07K2317/565A01K2267/01A01K2207/15A01K2227/105A01K2217/075A01K2217/072A01K2217/15C07K2318/10C07K16/461C07K2317/10C07K2317/20C07K2317/24C07K2317/51C07K2317/56C07K2317/567C07K14/7158C07K16/462C07K14/43504C12N15/8509C12N2510/04C12N2015/8518C07K2317/21C07K2317/52C07K2317/76C07K2317/92
Inventor L·麦克唐纳J·麦克沃克A·J·莫菲
Owner REGENERON PHARM INC